|1.||Callan, Robert L: 1 article (01/2010)|
|2.||Rao, Sangeeta: 1 article (01/2010)|
|3.||Ashton, Laura V: 1 article (01/2010)|
|4.||Landolt, Gabriele A: 1 article (01/2010)|
|5.||La Frazia, Simone: 1 article (10/2009)|
|6.||Santoro, M Gabriella: 1 article (10/2009)|
|7.||Ciucci, Alessandra: 1 article (10/2009)|
|8.||Chiappa, Lucia: 1 article (10/2009)|
|9.||Rossignol, Jean François: 1 article (10/2009)|
|10.||Piliado, Juan Carlos: 1 article (02/2007)|
|1.||Human Influenza (Influenza)
10/23/2009 - "Herein we document the anti-influenza activity of the anti-infective drug nitazoxanide and its active circulating-metabolite tizoxanide and describe a class of second generation thiazolides effective against influenza A virus. "
01/01/2010 - "In Vitro Susceptibility of Canine Influenza A (H3N8) Virus to Nitazoxanide and Tizoxanide."
02/01/2007 - "In order to evaluate alternative treatment options, the in vitro efficacy of nitazoxanide, its main metabolite tizoxanide as well as the tizoxanide and albendazole sulphoxide combination was tested against Taenia crassiceps cysts. "
02/01/2007 - "Efficacy of nitazoxanide, tizoxanide and tizoxanide/albendazole sulphoxide combination against Taenia crassiceps cysts."
02/01/2007 - "crassiceps cysts were incubated in culture medium containing different concentrations of nitazoxanide, tizoxanide and albendazole sulphoxide (0.037-0.42 microg/mL). "